
1. tidsskr laegeforen. 1997 jan 10;117(1):23-6.

[hodgkin disease treated tromsø regional hospital 1985-93. diagnosis,
treatment, prognosis, quality life costs decentralized treatment].

[article norwegian]

norum j(1), wist e.

author information: 
(1)kreftavdelingen, regionsykehuset tromsø.

between 1985-93, 55 patients treated hodgkin's disease university
hospital tromsø. median diagnostic delay four months significant
prolonged delay connected lymphocyte predominance subgroup. the
chlvpp regimen shown risk factor herpes zoster virus infection.
the 5-year overall survival 90%. survivors experienced low frequency of
symptoms high level functioning. females reported significant
superior global quality life lower psychological distress and
fatigue score males. cost one quality-adjusted life year (qaly)
(production gains included using 10% discount rate) estimated be
1,651 pounds. makes hodgkin's disease one cost-effective
malignancies treat.


pmid: 9064805  [indexed medline]

